首页 > 最新文献

Addiction Science & Clinical Practice最新文献

英文 中文
Mobile addiction treatment units: a narrative review. 移动成瘾治疗单位:叙述性回顾。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-24 DOI: 10.1186/s13722-025-00619-1
Irving Barrera, Grace Wang, Brammy Rajakumar, Siva Muthupalaniappan, Alexandria E Cronin, Avik Chatterjee
<p><strong>Background: </strong>Drug overdose deaths have increased in the last decade, becoming a substantial public health priority. Mobile Addiction Treatment Units (MATU) are vans, vehicles, or portable clinics that provide low-threshold, low-barrier, community-based services for addiction treatment including opioid agonist medications. MATUs are a point of entry for care, particularly for individuals who have faced barriers to access at in-person healthcare facilities.</p><p><strong>Objective: </strong>This narrative review aims to synthesize and conduct a thematic analysis of the research on implementation and outcomes of MATUs in the United States. Our study's primary objectives were threefold: 1) to evaluate MATU program reach, 2) to evaluate MATU program effectiveness, and 3) to evaluate MATU program implementation.</p><p><strong>Methods: </strong>We identified studies examining MATUs by searching electronic databases MEDLINE (Ovid), Embase (Elsevier), PsycINFO (EBSCO), and Web of Science Core Collection (Clarivate). Records were selected for full-text review if their abstract referenced any mobile modality for substance use treatments. Exclusion criteria included review articles, opinion articles, theoretical articles, abstracts, dissertations, studies conducted outside of the United States, and studies focused solely on mobile harm-reduction interventions without offering medication treatment for SUD. This review is reported per the Preferred Reporting Items of Systematic Reviews and Meta-Analyses for Scoping Review (PRISMA-ScR) guidelines.</p><p><strong>Results: </strong>A total of 2,232 articles were screened at the title and abstract level, of which 83 were assessed for full text eligibility. The 34 articles selected for inclusion were varied in methodology, and included randomized controlled trials (RCTs), observational studies, cohort studies, and mixed-methods research. The most common study locations were Baltimore, MD (10 studies), Boston, MA (5 studies), Philadelphia, PA (4 studies), and New Haven, CT (3 studies). Regarding reach, four studies were conducted during the COVID-19 pandemic. Six studies were conducted primarily in a population experiencing homelessness; two studies were conducted primarily in populations with criminal justice involvement; four studies were conducted primarily in youth or young-adult populations; three studies were conducted in rural populations. In these settings, MATUs successfully engaged vulnerable and underserved populations, delivering comprehensive care that combined harm reduction, primary care, and mental health services. These units demonstrated potential to enhance health outcomes, reduce stigma, increase treatment retention rates in marginalized populations compared to office-based programs, and tackle social determinants of health. Common challenges included patient engagement, logistical and regulatory barriers, and financial sustainability, all compounded by limited space, staffing,
背景:药物过量死亡在过去十年中有所增加,成为一个重要的公共卫生重点。移动成瘾治疗单位(MATU)是货车、车辆或便携式诊所,提供低门槛、低障碍、基于社区的成瘾治疗服务,包括阿片类激动剂药物。matu是获得护理的一个切入点,特别是对于那些在面对面的医疗保健设施中遇到障碍的个人。目的:本文旨在对美国matu的实施和成果研究进行综合和专题分析。我们研究的主要目标有三个:1)评估MATU计划的覆盖面,2)评估MATU计划的有效性,3)评估MATU计划的实施情况。方法:通过检索MEDLINE (Ovid)、Embase(爱思唯尔)、PsycINFO (EBSCO)和Web of Science Core Collection (Clarivate)等电子数据库,筛选有关MATUs的研究。如果其摘要引用了任何物质使用治疗的移动模式,则选择记录进行全文审查。排除标准包括评论文章、观点文章、理论文章、摘要、论文、在美国以外进行的研究,以及仅关注移动减少伤害干预措施而不提供SUD药物治疗的研究。本综述按照系统评价和荟萃分析范围评价(PRISMA-ScR)指南的首选报告项目进行报告。结果:共有2232篇文章在标题和摘要水平上被筛选,其中83篇文章被评估为符合全文资格。入选的34篇文章在方法学上各不相同,包括随机对照试验(RCTs)、观察性研究、队列研究和混合方法研究。最常见的研究地点是马里兰州巴尔的摩(10项研究)、马萨诸塞州波士顿(5项研究)、宾夕法尼亚州费城(4项研究)和康涅狄格州纽黑文(3项研究)。关于可及性,在COVID-19大流行期间进行了四项研究。六项研究主要在无家可归的人群中进行;两项研究主要在涉及刑事司法的人群中进行;四项研究主要在青年或年轻成人人群中进行;在农村人口中进行了三项研究。在这些环境中,matu成功地吸引了弱势群体和得不到充分服务的人群,提供综合护理,将减少伤害、初级保健和精神卫生服务结合起来。与以办公室为基础的项目相比,这些单位显示出改善健康结果、减少耻辱感、提高边缘化人群的治疗保留率以及解决健康的社会决定因素的潜力。共同的挑战包括患者参与、后勤和监管障碍以及财务可持续性,所有这些都因有限的空间、人员和资源而加剧,而无家可归、营地搬迁和COVID-19大流行进一步破坏了护理的连续性(J Subst Abuse treatment 120: 108149,2021; Front Public Health 11:1154813,2023; J Subst Use Addict treatment 159:209272, 2024; J Subst Use Addict treatment 164, 2024; Health Place 28:153-66, 2014;成瘾科学临床实践18:71,2023)。结论:事实证明,MATUs在解决传统上缺乏医疗服务的弱势群体的OUD和相关问题方面具有创新性和有效性。然而,不断努力克服执行方面的挑战,确保可持续的资金和资源,对其继续取得成功和扩大至关重要。今后的研究应集中于大规模、定量的研究,特别是在不同的农村环境中,以便更好地了解它们的长期影响和可持续性。
{"title":"Mobile addiction treatment units: a narrative review.","authors":"Irving Barrera, Grace Wang, Brammy Rajakumar, Siva Muthupalaniappan, Alexandria E Cronin, Avik Chatterjee","doi":"10.1186/s13722-025-00619-1","DOIUrl":"10.1186/s13722-025-00619-1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Drug overdose deaths have increased in the last decade, becoming a substantial public health priority. Mobile Addiction Treatment Units (MATU) are vans, vehicles, or portable clinics that provide low-threshold, low-barrier, community-based services for addiction treatment including opioid agonist medications. MATUs are a point of entry for care, particularly for individuals who have faced barriers to access at in-person healthcare facilities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This narrative review aims to synthesize and conduct a thematic analysis of the research on implementation and outcomes of MATUs in the United States. Our study's primary objectives were threefold: 1) to evaluate MATU program reach, 2) to evaluate MATU program effectiveness, and 3) to evaluate MATU program implementation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We identified studies examining MATUs by searching electronic databases MEDLINE (Ovid), Embase (Elsevier), PsycINFO (EBSCO), and Web of Science Core Collection (Clarivate). Records were selected for full-text review if their abstract referenced any mobile modality for substance use treatments. Exclusion criteria included review articles, opinion articles, theoretical articles, abstracts, dissertations, studies conducted outside of the United States, and studies focused solely on mobile harm-reduction interventions without offering medication treatment for SUD. This review is reported per the Preferred Reporting Items of Systematic Reviews and Meta-Analyses for Scoping Review (PRISMA-ScR) guidelines.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 2,232 articles were screened at the title and abstract level, of which 83 were assessed for full text eligibility. The 34 articles selected for inclusion were varied in methodology, and included randomized controlled trials (RCTs), observational studies, cohort studies, and mixed-methods research. The most common study locations were Baltimore, MD (10 studies), Boston, MA (5 studies), Philadelphia, PA (4 studies), and New Haven, CT (3 studies). Regarding reach, four studies were conducted during the COVID-19 pandemic. Six studies were conducted primarily in a population experiencing homelessness; two studies were conducted primarily in populations with criminal justice involvement; four studies were conducted primarily in youth or young-adult populations; three studies were conducted in rural populations. In these settings, MATUs successfully engaged vulnerable and underserved populations, delivering comprehensive care that combined harm reduction, primary care, and mental health services. These units demonstrated potential to enhance health outcomes, reduce stigma, increase treatment retention rates in marginalized populations compared to office-based programs, and tackle social determinants of health. Common challenges included patient engagement, logistical and regulatory barriers, and financial sustainability, all compounded by limited space, staffing, ","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"20 1","pages":"99"},"PeriodicalIF":3.2,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12729169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145828964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder. 提取GLP-1受体激动剂治疗酒精使用障碍的证据。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-24 DOI: 10.1186/s13722-025-00638-y
Eden Y Bernstein, Joseph P Schacht
{"title":"Distilling the evidence for GLP-1 receptor agonists in alcohol use disorder.","authors":"Eden Y Bernstein, Joseph P Schacht","doi":"10.1186/s13722-025-00638-y","DOIUrl":"10.1186/s13722-025-00638-y","url":null,"abstract":"","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"20 1","pages":"98"},"PeriodicalIF":3.2,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12729087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145822039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a collegiate recovery program from the ground up: identifying priorities, promoting collaboration, assessing needs, and offering recommendations. 从头开始制定大学恢复计划:确定优先事项,促进合作,评估需求,并提供建议。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-24 DOI: 10.1186/s13722-025-00630-6
Mary B Tabit
{"title":"Developing a collegiate recovery program from the ground up: identifying priorities, promoting collaboration, assessing needs, and offering recommendations.","authors":"Mary B Tabit","doi":"10.1186/s13722-025-00630-6","DOIUrl":"10.1186/s13722-025-00630-6","url":null,"abstract":"","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":" ","pages":"16"},"PeriodicalIF":3.2,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12849549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145822067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using a quality improvement framework to evaluate the feasibility of implementing a patient-reported outcome measure for recovery in an office-based treatment setting for opioid use disorder. 使用质量改进框架评估在阿片类药物使用障碍的办公室治疗环境中实施患者报告的康复结果措施的可行性。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-22 DOI: 10.1186/s13722-025-00632-4
Elisabeth Okrant, Sharon Reif, Genie L Bailey, Constance M Horgan, Margaret T Lee, Madeline A Brown, Blaire L Simas, Karen A Alfaro, Grant A Ritter
{"title":"Using a quality improvement framework to evaluate the feasibility of implementing a patient-reported outcome measure for recovery in an office-based treatment setting for opioid use disorder.","authors":"Elisabeth Okrant, Sharon Reif, Genie L Bailey, Constance M Horgan, Margaret T Lee, Madeline A Brown, Blaire L Simas, Karen A Alfaro, Grant A Ritter","doi":"10.1186/s13722-025-00632-4","DOIUrl":"10.1186/s13722-025-00632-4","url":null,"abstract":"","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":" ","pages":"15"},"PeriodicalIF":3.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12837188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145812375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facilitator perspectives on in-person versus videoconference delivery of a remedial intervention for impaired drivers: a qualitative study. 调解员的观点,面对面与视频会议交付对受损司机的补救干预:一项定性研究。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-22 DOI: 10.1186/s13722-025-00626-2
Chloe Docherty, Jennifer Rup, Gina Stoduto, Susan Labadia, Heulwen A Williams, Rosely Flam-Zalcman, Tinsae Neamen, Branka Agic, Nigel Turner, Wei Wang, Christine M Wickens
{"title":"Facilitator perspectives on in-person versus videoconference delivery of a remedial intervention for impaired drivers: a qualitative study.","authors":"Chloe Docherty, Jennifer Rup, Gina Stoduto, Susan Labadia, Heulwen A Williams, Rosely Flam-Zalcman, Tinsae Neamen, Branka Agic, Nigel Turner, Wei Wang, Christine M Wickens","doi":"10.1186/s13722-025-00626-2","DOIUrl":"10.1186/s13722-025-00626-2","url":null,"abstract":"","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":" ","pages":"5"},"PeriodicalIF":3.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12805713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145812207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails. 阿片类药物使用障碍实施对监狱环境中精神卫生服务和物质使用咨询的感知影响:来自马萨诸塞州13所监狱的定性研究结果。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-22 DOI: 10.1186/s13722-025-00641-3
Ekaterina Pivovarova, Peter D Friedmann, Warren Ferguson, Benjamin J Bovell Ammon, Thomas J Stopka, Elizabeth A Evans

Background: Although research on Medications for Opioid Use Disorder (MOUD) in carceral settings has grown, it has largely focused on the implementation of medication delivery or on substance use outcomes in the community. However, the introduction of new programs or the expansion of treatment services in criminal legal settings can have both direct and indirect consequences on other treatment programs and correctional operations within jails. Mental health and substance use disorders frequently co-occur, and their psychosocial treatment components often overlap. We examined how the implementation of MOUD in all jails across Massachusetts impacted the mental health services operating within the jails and the requirements for substance use counseling alongside MOUD.

Methods: We conducted semi-structured interviews (n = 47) and focus groups (n = 42) with staff from 13 county jails as part of an implementation of MOUD in jails study. Using deductive and inductive coding, all transcripts were double-coded and analyzed using a modified framework method.

Results: We identified five key themes about the perceived impact of MOUD on mental health and substance use counseling services. First, MOUD implementation was perceived to reduce acute mental health crises, such as risk for suicide, and the demand on mental health services at intake to the facility. Second, staff perceptions about the effectiveness of MOUD as a stand-alone treatment influenced their decisions about the need for and interpretation of substance use counseling requirements. Third, the required components of substance use counseling created a need for additional staff, which exacerbated the existing shortage of mental health staff. Fourth, infrastructure limitations and privacy needs made the delivery of substance use counseling logistically challenging in jail settings. Finally, MOUD implementation increased interdisciplinary collaboration in some jails by requiring medical, mental health, and substance use providers to work together to resolve the needs of incarcerated individuals.

Conclusions: As jails aim to meet regulatory requirements for MOUD, they will need to manage potential staffing shortages, infrastructure constraints, and shifts in the mental health and substance use counseling services. Guidelines for implementing MOUD in carceral settings should also consider the unintended consequences of MOUD on other behavioral health services.

背景:尽管在医疗环境中对阿片类药物使用障碍(mod)的研究有所增长,但它主要集中在社区药物递送或物质使用结果的实施上。然而,在刑事法律环境中引入新方案或扩大治疗服务可能对其他治疗方案和监狱内的矫正行动产生直接和间接的影响。精神健康和物质使用障碍经常同时发生,其心理社会治疗内容经常重叠。我们研究了在马萨诸塞州所有监狱中实施mod是如何影响监狱内的心理健康服务的,以及与mod一起对物质使用咨询的要求。方法:我们对来自13个县监狱的工作人员进行了半结构化访谈(n = 47)和焦点小组(n = 42),作为在监狱中实施mod研究的一部分。采用演绎和归纳编码,对所有转录本进行双重编码,并使用改进的框架方法进行分析。结果:我们确定了关于mod对心理健康和物质使用咨询服务的感知影响的五个关键主题。首先,人们认为实施mod可以减少严重的精神健康危机,例如自杀风险,并减少设施接收时对精神卫生服务的需求。第二,工作人员对mod作为一种独立治疗的有效性的看法影响了他们对物质使用咨询要求的需求和解释的决定。第三,药物使用咨询所需的组成部分需要额外的工作人员,这加剧了精神卫生工作人员的现有短缺。第四,基础设施的限制和隐私需求使得在监狱环境中提供药物使用咨询在后勤上具有挑战性。最后,mod的实施增加了一些监狱的跨学科合作,要求医疗、心理健康和药物使用提供者共同努力解决被监禁人员的需求。结论:由于监狱的目标是满足mod的监管要求,他们将需要管理潜在的人员短缺、基础设施限制以及心理健康和物质使用咨询服务的转变。在监狱环境中实施mod的指导方针还应考虑mod对其他行为卫生服务的意外后果。
{"title":"Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails.","authors":"Ekaterina Pivovarova, Peter D Friedmann, Warren Ferguson, Benjamin J Bovell Ammon, Thomas J Stopka, Elizabeth A Evans","doi":"10.1186/s13722-025-00641-3","DOIUrl":"10.1186/s13722-025-00641-3","url":null,"abstract":"<p><strong>Background: </strong>Although research on Medications for Opioid Use Disorder (MOUD) in carceral settings has grown, it has largely focused on the implementation of medication delivery or on substance use outcomes in the community. However, the introduction of new programs or the expansion of treatment services in criminal legal settings can have both direct and indirect consequences on other treatment programs and correctional operations within jails. Mental health and substance use disorders frequently co-occur, and their psychosocial treatment components often overlap. We examined how the implementation of MOUD in all jails across Massachusetts impacted the mental health services operating within the jails and the requirements for substance use counseling alongside MOUD.</p><p><strong>Methods: </strong>We conducted semi-structured interviews (n = 47) and focus groups (n = 42) with staff from 13 county jails as part of an implementation of MOUD in jails study. Using deductive and inductive coding, all transcripts were double-coded and analyzed using a modified framework method.</p><p><strong>Results: </strong>We identified five key themes about the perceived impact of MOUD on mental health and substance use counseling services. First, MOUD implementation was perceived to reduce acute mental health crises, such as risk for suicide, and the demand on mental health services at intake to the facility. Second, staff perceptions about the effectiveness of MOUD as a stand-alone treatment influenced their decisions about the need for and interpretation of substance use counseling requirements. Third, the required components of substance use counseling created a need for additional staff, which exacerbated the existing shortage of mental health staff. Fourth, infrastructure limitations and privacy needs made the delivery of substance use counseling logistically challenging in jail settings. Finally, MOUD implementation increased interdisciplinary collaboration in some jails by requiring medical, mental health, and substance use providers to work together to resolve the needs of incarcerated individuals.</p><p><strong>Conclusions: </strong>As jails aim to meet regulatory requirements for MOUD, they will need to manage potential staffing shortages, infrastructure constraints, and shifts in the mental health and substance use counseling services. Guidelines for implementing MOUD in carceral settings should also consider the unintended consequences of MOUD on other behavioral health services.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":" ","pages":"11"},"PeriodicalIF":3.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12825220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145812336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment. 在家庭医学中实施阿片类药物使用障碍治疗的激励措施:对提供者和患者对与丁丙诺啡治疗相容的低强度奖励计划的偏好进行定性调查。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-22 DOI: 10.1186/s13722-025-00621-7
Samantha Ellis, Jax Witzig, Diego Basaldu, Brittany Rudd, Nicole Gastala, Alexandra R Tabachnick, Sungha Kang, Tondalaya Henry, Nathan Stackhouse, Margaret Wardle

Background: Incentive programs are an effective yet underutilized behavioral intervention that can improve outcomes in medication for opioid use disorder (MOUD) treatment. Contingency Management (CM) is a rigorous incentive program run per seven evidence-based principles (e.g. objectively verifiable target behaviors, frequent opportunities for incentives). Prior implementation attempts have focused on implementing CM in specialized addiction clinics with methadone as the primary medication treatment. However, many people get MOUD from less specialized, more accessible family medicine clinics. These clinics might also benefit from the use of incentive programs, yet present unique challenges for implementation. For example, family medicine clinics typically use buprenorphine as their primary medication, which requires less intensive dosing schedules than methadone and thus provides fewer incentive opportunities. As an initial step in user-centered design of a CM-informed incentive program for the family medicine context, we conducted qualitative interviews with patients and staff in the buprenorphine treatment program of a family medicine department. We gathered and analyzed qualitative data on CM knowledge, preferred program parameters, and implementation considerations.

Method: Participants (N = 24) were buprenorphine treatment staff (n = 12) and patients (n = 12). Participants completed 30-50-minute semi-structured interviews, analyzed using rapid matrix analysis.

Results: Participants had little experience with formal incentive programs, but generally viewed incentives as acceptable, appropriate, and feasible. Interviewees coalesced around having staff who were not MOUD prescribers run the program, consistent rather than escalating payments, and physical rewards delivered in-person. Potential challenges included medical record integration, demands on staff time, and confirmation of patients' goal completion.

Conclusions: Patient and staff feedback was well-aligned, especially regarding rewards as an opportunity for staff-patient connection and the need for simplicity. Comparing end-user suggestions with the literature, some consensus suggestions (e.g. non-escalating rewards) highlighted feasible places to compromise on ideal effectiveness to gain implementability. However, others (e.g. use of self-report to verify goals) conflicted directly with CM principles and indicate where more intensive education, support, and monitoring will be needed for implementation fidelity. These findings inform user-centered design and iteration of an incentive program for this accessible, non-specialized family medicine setting.

背景:激励计划是一种有效但未充分利用的行为干预措施,可以改善阿片类药物使用障碍(mod)治疗的结果。应急管理(CM)是一个严格的激励计划,根据七个基于证据的原则运行(例如,客观可验证的目标行为,频繁的激励机会)。先前的实施尝试侧重于在以美沙酮为主要药物治疗的专业成瘾诊所实施CM。然而,许多人从不太专业、更容易进入的家庭医疗诊所获得mod。这些诊所也可能从激励计划的使用中受益,但在实施方面存在独特的挑战。例如,家庭医学诊所通常使用丁丙诺啡作为主要药物,与美沙酮相比,丁丙诺啡需要的剂量计划不那么密集,因此提供的激励机会较少。作为以用户为中心的家庭医学cm激励方案设计的第一步,我们对家庭医学系丁丙诺啡治疗方案的患者和工作人员进行了定性访谈。我们收集并分析了关于配置管理知识、首选程序参数和实现考虑的定性数据。方法:研究对象为丁丙诺啡治疗人员(N = 12)和患者(N = 12),共24例。参与者完成了30-50分钟的半结构化访谈,使用快速矩阵分析进行分析。结果:参与者很少有正式激励计划的经验,但通常认为激励是可接受的,适当的,可行的。受访者一致认为,让非mod处方者的员工来管理这个项目,保持一致而不是不断升级的支付,并亲自发放实物奖励。潜在的挑战包括医疗记录整合、对员工时间的要求以及确认患者目标的完成。结论:患者和工作人员的反馈是一致的,特别是关于奖励作为一个工作人员与患者联系的机会和简化的需要。将最终用户建议与文献进行比较,一些共识建议(例如,不升级奖励)突出了在理想有效性上妥协以获得可实施性的可行地方。然而,其他的(例如,使用自我报告来验证目标)直接与配置管理原则相冲突,并指出在哪些地方需要更密集的教育、支持和监控来实现保真度。这些发现为以用户为中心的设计提供了信息,并为无障碍、非专业的家庭医学环境提供了激励方案。
{"title":"Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment.","authors":"Samantha Ellis, Jax Witzig, Diego Basaldu, Brittany Rudd, Nicole Gastala, Alexandra R Tabachnick, Sungha Kang, Tondalaya Henry, Nathan Stackhouse, Margaret Wardle","doi":"10.1186/s13722-025-00621-7","DOIUrl":"10.1186/s13722-025-00621-7","url":null,"abstract":"<p><strong>Background: </strong>Incentive programs are an effective yet underutilized behavioral intervention that can improve outcomes in medication for opioid use disorder (MOUD) treatment. Contingency Management (CM) is a rigorous incentive program run per seven evidence-based principles (e.g. objectively verifiable target behaviors, frequent opportunities for incentives). Prior implementation attempts have focused on implementing CM in specialized addiction clinics with methadone as the primary medication treatment. However, many people get MOUD from less specialized, more accessible family medicine clinics. These clinics might also benefit from the use of incentive programs, yet present unique challenges for implementation. For example, family medicine clinics typically use buprenorphine as their primary medication, which requires less intensive dosing schedules than methadone and thus provides fewer incentive opportunities. As an initial step in user-centered design of a CM-informed incentive program for the family medicine context, we conducted qualitative interviews with patients and staff in the buprenorphine treatment program of a family medicine department. We gathered and analyzed qualitative data on CM knowledge, preferred program parameters, and implementation considerations.</p><p><strong>Method: </strong>Participants (N = 24) were buprenorphine treatment staff (n = 12) and patients (n = 12). Participants completed 30-50-minute semi-structured interviews, analyzed using rapid matrix analysis.</p><p><strong>Results: </strong>Participants had little experience with formal incentive programs, but generally viewed incentives as acceptable, appropriate, and feasible. Interviewees coalesced around having staff who were not MOUD prescribers run the program, consistent rather than escalating payments, and physical rewards delivered in-person. Potential challenges included medical record integration, demands on staff time, and confirmation of patients' goal completion.</p><p><strong>Conclusions: </strong>Patient and staff feedback was well-aligned, especially regarding rewards as an opportunity for staff-patient connection and the need for simplicity. Comparing end-user suggestions with the literature, some consensus suggestions (e.g. non-escalating rewards) highlighted feasible places to compromise on ideal effectiveness to gain implementability. However, others (e.g. use of self-report to verify goals) conflicted directly with CM principles and indicate where more intensive education, support, and monitoring will be needed for implementation fidelity. These findings inform user-centered design and iteration of an incentive program for this accessible, non-specialized family medicine setting.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"20 1","pages":"97"},"PeriodicalIF":3.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12723837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145812239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of different exercise types on craving in substance use disorder patients with drug dependence -network meta-analysis and dose-response relationships based on frequentist and Bayesian models. 不同运动类型对药物依赖患者渴望的影响——基于频率模型和贝叶斯模型的网络meta分析及剂量-反应关系
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-18 DOI: 10.1186/s13722-025-00639-x
Chuanqiushui Wang, Yi Yang, Kun Wang, Liang Sun, Shi Qi Liu, Jiong Luo

Background: Exercise interventions have been shown to effectively reduce drug craving and improve physical and mental health in patients with substance use disorders (SUDs). However, the optimal type and amount of exercise needed to maximize these benefits for SUDs is not fully understood and warrants further investigation.

Methods: A comprehensive search strategy was implemented in four electronic databases (i.e., PubMed, Web of Science, CNKI, and EMBASE) to identify randomized controlled trials examining the impact of exercise on craving in individuals with substance use disorders. Network meta-analysis and dose-response modeling were employed to assess the specific benefits of exercise on craving.

Results: The analysis incorporated a total of 30 randomized controlled trials, encompassing a total of 1,717 subjects. These subjects were comprised of 1,258 male participants (73.26%) and 459 female participants (26.73%). The results of the meta-analysis demonstrated that there was a low grade GRADE evidence suggesting that, in comparison with the control group, aerobic exercise (SMD= -0.73, 95%CI: -1.06 to -0.41), high-intensity interval exercise (SMD= -2.19, 95%CI: -3.90 to -0.49), and aerobic combined with resistance exercise (SMD= -1.96, 95%CI: -2.92 to -1.00) were more effective than the control group. Subgroup analyses revealed positive effects of acute aerobic exercise (SMD= -0.23, 95%CI: -0.41 to -0.04, I²=22%) and long-term aerobic exercise (SMD= -0.46, 95%CI: -0.72 to -0.21, I²=0%) on cravings. Furthermore, the results found that Taijiquan significantly reduced drug craving (SMD= -0.47, 95%CI: -0.70 to -0.24, I²=0%) in the subjects. The dosage analysis revealed that the effective range of total exercise for reducing craving in individuals with substance use disorder was from 20 to 320 METs-min/week (SMD= -0.58, 95%CI: -0.8 to -0.28 to SMD= -0.72, 95%CI: -0.91 to -0.46). The optimal form of exercise was determined to be aerobic exercise, with an optimal exercise dose of 180 METs-min/week, which resulted in an estimated mean difference of -1.46 (95%CI: -2.04 to -0.96). The regression analysis results indicated that the impact of exercise on subjects' cravings may be influenced by their age level (β= -0.995, 95%CI: -2.002 to -0.011).

Conclusion: Aerobic exercise has been recognized as the most effective form of exercise for alleviating drug cravings in individuals with substance use disorders (SUDs). Research indicates that the exercise dose for SUDs exhibits characteristics of low-dose effectiveness and plateaus in its effects. The optimal total intervention dose is best sustained at 180 METs-min/week, which is equivalent to three 60-minute sessions of moderate-intensity aerobic exercise each week.

Clinical trial registration details: Not applicable.

Prospero registration details: CRD420251004497.

背景:运动干预已被证明可以有效地减少药物渴望,改善物质使用障碍(sud)患者的身心健康。然而,对于sud而言,最大化这些益处所需的最佳运动类型和运动量尚不完全清楚,需要进一步研究。方法:在四个电子数据库(PubMed, Web of Science, CNKI和EMBASE)中实施综合搜索策略,以确定随机对照试验,研究运动对物质使用障碍个体渴望的影响。网络荟萃分析和剂量反应模型被用来评估运动对渴望的具体益处。结果:本分析共纳入30项随机对照试验,共计1717名受试者。其中男性1258人(73.26%),女性459人(26.73%)。meta分析结果显示,低等级grade证据表明,与对照组相比,有氧运动(SMD= -0.73, 95%CI: -1.06 ~ -0.41)、高强度间歇运动(SMD= -2.19, 95%CI: -3.90 ~ -0.49)和有氧结合阻力运动(SMD= -1.96, 95%CI: -2.92 ~ -1.00)比对照组更有效。亚组分析显示,急性有氧运动(SMD= -0.23, 95%CI: -0.41至-0.04,I²=22%)和长期有氧运动(SMD= -0.46, 95%CI: -0.72至-0.21,I²=0%)对食欲有积极影响。此外,结果发现太极拳显著降低了受试者的药物渴望(SMD= -0.47, 95%CI: -0.70 ~ -0.24, I²=0%)。剂量分析显示,总运动量对物质使用障碍个体减少渴望的有效范围为20 ~ 320 met -min/week (SMD= -0.58, 95%CI: -0.8 ~ -0.28 ~ SMD= -0.72, 95%CI: -0.91 ~ -0.46)。最佳运动形式被确定为有氧运动,最佳运动剂量为180 met -min/周,估计平均差异为-1.46 (95%CI: -2.04至-0.96)。回归分析结果显示,运动对被试食欲的影响可能受到年龄水平的影响(β= -0.995, 95%CI: -2.002 ~ -0.011)。结论:有氧运动已被认为是缓解物质使用障碍(sud)患者对药物渴望的最有效的运动形式。研究表明,运动剂量对sud的作用表现出低剂量有效和效应稳定的特点。最佳总干预剂量最好维持在180 met -min/周,相当于每周进行三次60分钟的中等强度有氧运动。临床试验注册详情:不适用。普洛斯彼罗注册详情:CRD420251004497。
{"title":"Effects of different exercise types on craving in substance use disorder patients with drug dependence -network meta-analysis and dose-response relationships based on frequentist and Bayesian models.","authors":"Chuanqiushui Wang, Yi Yang, Kun Wang, Liang Sun, Shi Qi Liu, Jiong Luo","doi":"10.1186/s13722-025-00639-x","DOIUrl":"10.1186/s13722-025-00639-x","url":null,"abstract":"<p><strong>Background: </strong>Exercise interventions have been shown to effectively reduce drug craving and improve physical and mental health in patients with substance use disorders (SUDs). However, the optimal type and amount of exercise needed to maximize these benefits for SUDs is not fully understood and warrants further investigation.</p><p><strong>Methods: </strong>A comprehensive search strategy was implemented in four electronic databases (i.e., PubMed, Web of Science, CNKI, and EMBASE) to identify randomized controlled trials examining the impact of exercise on craving in individuals with substance use disorders. Network meta-analysis and dose-response modeling were employed to assess the specific benefits of exercise on craving.</p><p><strong>Results: </strong>The analysis incorporated a total of 30 randomized controlled trials, encompassing a total of 1,717 subjects. These subjects were comprised of 1,258 male participants (73.26%) and 459 female participants (26.73%). The results of the meta-analysis demonstrated that there was a low grade GRADE evidence suggesting that, in comparison with the control group, aerobic exercise (SMD= -0.73, 95%CI: -1.06 to -0.41), high-intensity interval exercise (SMD= -2.19, 95%CI: -3.90 to -0.49), and aerobic combined with resistance exercise (SMD= -1.96, 95%CI: -2.92 to -1.00) were more effective than the control group. Subgroup analyses revealed positive effects of acute aerobic exercise (SMD= -0.23, 95%CI: -0.41 to -0.04, I²=22%) and long-term aerobic exercise (SMD= -0.46, 95%CI: -0.72 to -0.21, I²=0%) on cravings. Furthermore, the results found that Taijiquan significantly reduced drug craving (SMD= -0.47, 95%CI: -0.70 to -0.24, I²=0%) in the subjects. The dosage analysis revealed that the effective range of total exercise for reducing craving in individuals with substance use disorder was from 20 to 320 METs-min/week (SMD= -0.58, 95%CI: -0.8 to -0.28 to SMD= -0.72, 95%CI: -0.91 to -0.46). The optimal form of exercise was determined to be aerobic exercise, with an optimal exercise dose of 180 METs-min/week, which resulted in an estimated mean difference of -1.46 (95%CI: -2.04 to -0.96). The regression analysis results indicated that the impact of exercise on subjects' cravings may be influenced by their age level (β= -0.995, 95%CI: -2.002 to -0.011).</p><p><strong>Conclusion: </strong>Aerobic exercise has been recognized as the most effective form of exercise for alleviating drug cravings in individuals with substance use disorders (SUDs). Research indicates that the exercise dose for SUDs exhibits characteristics of low-dose effectiveness and plateaus in its effects. The optimal total intervention dose is best sustained at 180 METs-min/week, which is equivalent to three 60-minute sessions of moderate-intensity aerobic exercise each week.</p><p><strong>Clinical trial registration details: </strong>Not applicable.</p><p><strong>Prospero registration details: </strong>CRD420251004497.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":" ","pages":"12"},"PeriodicalIF":3.2,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12825257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation outcomes and strategies of a peer recovery coach program: findings from a qualitative assessment in the U.S. South, 2024-2025. 同伴康复教练项目的实施结果和策略:来自美国南部定性评估的结果,2024-2025。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-18 DOI: 10.1186/s13722-025-00624-4
Umedjon Ibragimov, Nicholas A Giordano, Sneha Amaresh, Tatiana Getz, Tatiana Matuszewski, Alaina R Steck, Yan Li, Eliot H Blum, Jessica Tuttle, Hardik Pipalia, Hannah L F Cooper, Joseph E Carpenter

Introduction: Successful implementation of peer recovery coach (PRC) programs may help improve linkage to services and clinical outcomes for emergency department (ED) patients with substance use disorder (SUD). However, literature on implementation outcomes and strategies of PRC programs is limited. We conducted a qualitative assessment of implementation outcomes and strategies for an ED-based PRC program in Atlanta, Georgia.

Methods: We conducted qualitative interviews with 27 program participants (ED patients with SUD served by PRC program) and 29 service providers and partners (peer recovery coaches, ED physicians and staff, SUD treatment and other service providers) in October 2023 - March 2025. We transcribed audio-recordings and analyzed data using rapid qualitative analysis approach mapping emerging themes to Proctor's model of implementation outcomes and Leeman et al.'s implementation strategies framework.

Results: We identified two major themes related to implementation outcomes: (1) PRC program acceptability (patients' positive interactions with PRCs) and (2) appropriateness (sub-themes include: successful linkage to community services; PRC program as an important resource for patients; added value of PRC team; no negative impact on ED workflow). Themes related to implementation strategies include (1) streamlined communication between PRC and ED teams (direct communication via electronic medical records system, single contact phone number, informing ED service providers of clinical and program outcomes), (2) addressing barriers to community-based services (preparing patient's medical documentation, insurance, transportation to community services); (3) supportive supervision of PRCs (addressing daily and long-term issues through regular meetings; limiting caseload; and providing orientation, on-job training and mental health support) and (4) addressing telehealth implementation challenges (ensuring access to electronic medical records system).

Conclusion: This study outlines key implementation outcomes and strategies for PRC programs, offering practical guidance for successful ED-based PRC program implementation.

导读:同伴康复教练(PRC)项目的成功实施可能有助于改善急诊科(ED)药物使用障碍(SUD)患者与服务和临床结果的联系。然而,关于PRC项目实施结果和策略的文献是有限的。我们对佐治亚州亚特兰大市一个基于教育的PRC项目的实施结果和策略进行了定性评估。方法:我们于2023年10月至2025年3月对27名项目参与者(PRC项目服务的ED患者)和29名服务提供者和合作伙伴(同伴康复教练、ED医生和工作人员、SUD治疗和其他服务提供者)进行定性访谈。我们对录音进行转录,并使用快速定性分析方法分析数据,将新兴主题映射到Proctor的实施结果模型和Leeman等人的实施战略框架中。结果:我们确定了与实施结果相关的两个主要主题:(1)PRC计划的可接受性(患者与PRC的积极互动)和(2)适当性(子主题包括:与社区服务的成功联系;PRC计划作为患者的重要资源;PRC团队的附加价值;对ED工作流程没有负面影响)。与实施战略相关的主题包括:(1)简化中华人民共和国和急诊科团队之间的沟通(通过电子病历系统直接沟通,单一联系电话号码,通知急诊科服务提供者临床和项目结果),(2)解决社区服务的障碍(准备患者的医疗文件,保险,前往社区服务的交通);(3)对prc进行支持性监督(通过定期会议解决日常和长期问题;限制病例量;提供指导、在职培训和心理健康支持)和(4)解决远程医疗实施方面的挑战(确保使用电子病历系统)。结论:本研究概述了中华人民共和国项目的关键实施成果和战略,为成功实施基于教育的中华人民共和国项目提供了实践指导。
{"title":"Implementation outcomes and strategies of a peer recovery coach program: findings from a qualitative assessment in the U.S. South, 2024-2025.","authors":"Umedjon Ibragimov, Nicholas A Giordano, Sneha Amaresh, Tatiana Getz, Tatiana Matuszewski, Alaina R Steck, Yan Li, Eliot H Blum, Jessica Tuttle, Hardik Pipalia, Hannah L F Cooper, Joseph E Carpenter","doi":"10.1186/s13722-025-00624-4","DOIUrl":"10.1186/s13722-025-00624-4","url":null,"abstract":"<p><strong>Introduction: </strong>Successful implementation of peer recovery coach (PRC) programs may help improve linkage to services and clinical outcomes for emergency department (ED) patients with substance use disorder (SUD). However, literature on implementation outcomes and strategies of PRC programs is limited. We conducted a qualitative assessment of implementation outcomes and strategies for an ED-based PRC program in Atlanta, Georgia.</p><p><strong>Methods: </strong>We conducted qualitative interviews with 27 program participants (ED patients with SUD served by PRC program) and 29 service providers and partners (peer recovery coaches, ED physicians and staff, SUD treatment and other service providers) in October 2023 - March 2025. We transcribed audio-recordings and analyzed data using rapid qualitative analysis approach mapping emerging themes to Proctor's model of implementation outcomes and Leeman et al.'s implementation strategies framework.</p><p><strong>Results: </strong>We identified two major themes related to implementation outcomes: (1) PRC program acceptability (patients' positive interactions with PRCs) and (2) appropriateness (sub-themes include: successful linkage to community services; PRC program as an important resource for patients; added value of PRC team; no negative impact on ED workflow). Themes related to implementation strategies include (1) streamlined communication between PRC and ED teams (direct communication via electronic medical records system, single contact phone number, informing ED service providers of clinical and program outcomes), (2) addressing barriers to community-based services (preparing patient's medical documentation, insurance, transportation to community services); (3) supportive supervision of PRCs (addressing daily and long-term issues through regular meetings; limiting caseload; and providing orientation, on-job training and mental health support) and (4) addressing telehealth implementation challenges (ensuring access to electronic medical records system).</p><p><strong>Conclusion: </strong>This study outlines key implementation outcomes and strategies for PRC programs, offering practical guidance for successful ED-based PRC program implementation.</p>","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":"20 1","pages":"95"},"PeriodicalIF":3.2,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. NOD(纳曲酮预防过量)研究方案:一项随机对照试验,在使用兴奋剂的艾滋病毒感染者或有感染艾滋病毒风险的人群中,肌注纳曲酮预防阿片类药物过量。
IF 3.2 2区 医学 Q1 SUBSTANCE ABUSE Pub Date : 2025-12-15 DOI: 10.1186/s13722-025-00623-5
Ayesha Appa, Xochitl Luna Marti, Stefan Baral, Steven Shoptaw, Alexander R Bazazi, Matthew A Spinelli, Dave Glidden, Monica Gandhi, Phillip Coffin
{"title":"The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV.","authors":"Ayesha Appa, Xochitl Luna Marti, Stefan Baral, Steven Shoptaw, Alexander R Bazazi, Matthew A Spinelli, Dave Glidden, Monica Gandhi, Phillip Coffin","doi":"10.1186/s13722-025-00623-5","DOIUrl":"10.1186/s13722-025-00623-5","url":null,"abstract":"","PeriodicalId":54223,"journal":{"name":"Addiction Science & Clinical Practice","volume":" ","pages":"7"},"PeriodicalIF":3.2,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12805729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Addiction Science & Clinical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1